These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38627734)

  • 1. Optimizing cardiovascular disease mortality prediction: a super learner approach in the tehran lipid and glucose study.
    Darabi P; Gharibzadeh S; Khalili D; Bagherpour-Kalo M; Janani L
    BMC Med Inform Decis Mak; 2024 Apr; 24(1):97. PubMed ID: 38627734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of obesity phenotype changes on cardiovascular outcomes in adults older than 40 years in the prospective cohort of the Tehran lipids and glucose study (TLGS): joint model of longitudinal and time-to-event data.
    Sedaghat Z; Khodakarim S; Sabour S; Valizadeh M; Barzin M; Nejadghaderi SA; Azizi F
    BMC Public Health; 2024 Apr; 24(1):1126. PubMed ID: 38654182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular disease risk prediction using automated machine learning: A prospective study of 423,604 UK Biobank participants.
    Alaa AM; Bolton T; Di Angelantonio E; Rudd JHF; van der Schaar M
    PLoS One; 2019; 14(5):e0213653. PubMed ID: 31091238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weight fluctuation, mortality, and cardiovascular disease in adults in 18 years of follow-up: Tehran Lipid and Glucose Study.
    Mehran L; Honarvar M; Masoumi S; Khalili D; Amouzegar A; Azizi F
    J Endocrinol Invest; 2023 Jan; 46(1):37-49. PubMed ID: 35921037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weight change and risk of cardiovascular disease among adults with type 2 diabetes: more than 14 years of follow-up in the Tehran Lipid and Glucose Study.
    Moazzeni SS; Hizomi Arani R; Deravi N; Hasheminia M; Khalili D; Azizi F; Hadaegh F
    Cardiovasc Diabetol; 2021 Jul; 20(1):141. PubMed ID: 34253199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An innovative model for predicting coronary heart disease using triglyceride-glucose index: a machine learning-based cohort study.
    Mirjalili SR; Soltani S; Heidari Meybodi Z; Marques-Vidal P; Kraemer A; Sarebanhassanabadi M
    Cardiovasc Diabetol; 2023 Aug; 22(1):200. PubMed ID: 37542255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for cardiovascular disease and mortality events in adults with type 2 diabetes - a 10-year follow-up: Tehran Lipid and Glucose Study.
    Afsharian S; Akbarpour S; Abdi H; Sheikholeslami F; Moeini AS; Khalili D; Momenan AA; Azizi F; Hadaegh F
    Diabetes Metab Res Rev; 2016 Sep; 32(6):596-606. PubMed ID: 26787367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trajectories of cardiovascular disease risk and their association with the incidence of cardiovascular events over 18 years of follow-up: The Tehran Lipid and Glucose study.
    Koohi F; Ahmadi N; Hadaegh F; Safiee S; Azizi F; Khalili D
    J Transl Med; 2021 Jul; 19(1):309. PubMed ID: 34271961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of total cholesterol versus other serum lipid parameters with the short-term prediction of cardiovascular outcomes: Tehran Lipid and Glucose Study.
    Hadaegh F; Harati H; Ghanbarian A; Azizi F
    Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):571-7. PubMed ID: 16874147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BMI category-specific waist circumference thresholds based on cardiovascular disease outcomes and all-cause mortality: Tehran lipid and glucose study (TLGS).
    Seyedhoseinpour A; Barzin M; Mahdavi M; Valizadeh M; Azizi F; Ghareh S; Hosseinpanah F
    BMC Public Health; 2023 Jul; 23(1):1297. PubMed ID: 37407928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term incidence of cardiovascular outcomes in the middle-aged and elderly with different patterns of physical activity: Tehran lipid and glucose study.
    Naseri P; Amiri P; Masihay-Akbar H; Jalali-Farahani S; Khalili D; Azizi F
    BMC Public Health; 2020 Nov; 20(1):1654. PubMed ID: 33148219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-carbohydrate diet and cardiovascular diseases in Iranian population: Tehran Lipid and Glucose Study.
    Farhadnejad H; Asghari G; Teymoori F; Tahmasebinejad Z; Mirmiran P; Azizi F
    Nutr Metab Cardiovasc Dis; 2020 Apr; 30(4):581-588. PubMed ID: 32008914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 12-year trends in cardiovascular risk factors (2002-2005 through 2011-2014) in patients with cardiovascular diseases: Tehran lipid and glucose study.
    Rabani S; Sardarinia M; Akbarpour S; Azizi F; Khalili D; Hadaegh F
    PLoS One; 2018; 13(5):e0195543. PubMed ID: 29768511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of triglyceride-glucose index on incident cardiovascular events during 16 years of follow-up: Tehran Lipid and Glucose Study.
    Barzegar N; Tohidi M; Hasheminia M; Azizi F; Hadaegh F
    Cardiovasc Diabetol; 2020 Sep; 19(1):155. PubMed ID: 32993633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between dietary glycemic and insulin indices with incidence of cardiovascular disease: Tehran lipid and glucose study.
    Teymoori F; Farhadnejad H; Mirmiran P; Nazarzadeh M; Azizi F
    BMC Public Health; 2020 Oct; 20(1):1496. PubMed ID: 33008356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Dietary Diabetes Risk Reduction Score With Risk of Cardiovascular Diseases in the Iranian Population: Tehran Lipid and Glucose Study.
    Asghari G; Farhadnejad H; Teymoori F; Emamat H; Shahrzad MK; Habibi-Moeini AS; Mirmiran P; Azizi F
    Heart Lung Circ; 2022 Jan; 31(1):101-109. PubMed ID: 34176740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association of body mass index variability with cardiovascular disease and mortality: a mediation analysis of pooled cohorts.
    Mehran L; Honarvar M; Masoumi S; Khalili D; Azizi F; Blaha MJ; Amouzegar A
    Front Endocrinol (Lausanne); 2024; 15():1345781. PubMed ID: 38803477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can Predictive Modeling Tools Identify Patients at High Risk of Prolonged Opioid Use After ACL Reconstruction?
    Anderson AB; Grazal CF; Balazs GC; Potter BK; Dickens JF; Forsberg JA
    Clin Orthop Relat Res; 2020 Jul; 478(7):0-1618. PubMed ID: 32282466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive performances of lipid accumulation product vs. adiposity measures for cardiovascular diseases and all-cause mortality, 8.6-year follow-up: Tehran lipid and glucose study.
    Bozorgmanesh M; Hadaegh F; Azizi F
    Lipids Health Dis; 2010 Sep; 9():100. PubMed ID: 20846382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk Factors for Incidence of Cardiovascular Diseases and All-Cause Mortality in a Middle Eastern Population over a Decade Follow-up: Tehran Lipid and Glucose Study.
    Sardarinia M; Akbarpour S; Lotfaliany M; Bagherzadeh-Khiabani F; Bozorgmanesh M; Sheikholeslami F; Azizi F; Hadaegh F
    PLoS One; 2016; 11(12):e0167623. PubMed ID: 27930696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.